Evidence map›Paper›PMID 38090672›Full record

ArticleFrontiers in molecular biosciences2023

EspB and HtpG interact with the type III-A CRISPR/Cas system of

Mingmin Shi, Hongtai Zhang, Joy Fleming, Wenjing Wei, Hong Chen, Xiaowei Dai, Yi Liu, Chuanyou Li, Fanlei Ran, Zhilong Wu and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Mingmin Shi *Foshan Fourth People's Hospital, Foshan, China.
Hongtai Zhang *Beijing Center for Diseases Prevention and Control, Beijing, China.
Joy FlemingKey Laboratory of RNA Biology, State Key Laboratory of Biomacromolecules, CAS Center of Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, China.
Wenjing WeiKey Laboratory of RNA Biology, State Key Laboratory of Biomacromolecules, CAS Center of Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, China.
Hong ChenKey Laboratory of RNA Biology, State Key Laboratory of Biomacromolecules, CAS Center of Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, China.
Xiaowei DaiBeijing Center for Diseases Prevention and Control, Beijing, China.
Yi LiuBiobank of Beijing Chest Hospital, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Chuanyou LiBeijing Center for Diseases Prevention and Control, Beijing, China.
Fanlei RanKey Laboratory of RNA Biology, State Key Laboratory of Biomacromolecules, CAS Center of Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, China.
Zhilong WuFoshan Fourth People's Hospital, Foshan, China.
Yaguo WangTB Healthcare Co., Ltd., Foshan, China.
Xilin ZhangFoshan Fourth People's Hospital, Foshan, China.
Huizhi ZhangKey Laboratory of Biomedicine, Innovation and Development Research Institute of International Eurasian Academy of Sciences, Beijing, China.
Lijun BiKey Laboratory of RNA Biology, State Key Laboratory of Biomacromolecules, CAS Center of Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, China.
Beijing Center for Disease Prevention and Control · CNInstitute of Biophysics · CNThe Fourth People's Hospital · CNBeijing Chest Hospital · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR/Cas systemCsmEspBHtpGMycobacterium tuberculosis

Identifiers

PMID38090672
PMCPMC10715591
OpenAlexW4389053450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.